Form 8-K - Current report:
SEC Accession No. 0001104659-19-019416
Filing Date
2019-04-02
Accepted
2019-04-02 17:05:47
Documents
50
Period of Report
2019-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7596_18k.htm 8-K 86093
2 EX-2.1 a19-7596_1ex2d1.htm EX-2.1 508740
3 EX-10.1 a19-7596_1ex10d1.htm EX-10.1 236411
4 EX-10.2 a19-7596_1ex10d2.htm EX-10.2 228586
5 EX-10.3 a19-7596_1ex10d3.htm EX-10.3 354107
6 EX-10.4 a19-7596_1ex10d4.htm EX-10.4 272266
7 EX-10.5 a19-7596_1ex10d5.htm EX-10.5 215563
8 EX-10.6 a19-7596_1ex10d6.htm EX-10.6 103369
9 EX-10.11 a19-7596_1ex10d11.htm EX-10.11 23734
10 EX-10.12 a19-7596_1ex10d12.htm EX-10.12 23729
11 EX-10.13 a19-7596_1ex10d13.htm EX-10.13 23761
12 EX-10.14 a19-7596_1ex10d14.htm EX-10.14 535953
13 EX-99.1 a19-7596_1ex99d1.htm EX-99.1 1944965
14 EX-99.2 a19-7596_1ex99d2.htm EX-99.2 12996
15 GRAPHIC g75961mm19i001.jpg GRAPHIC 26666
16 GRAPHIC g75961mm19i002.jpg GRAPHIC 38940
17 GRAPHIC g75961mm19i003.jpg GRAPHIC 50501
18 GRAPHIC g75961mm23i001.jpg GRAPHIC 16936
19 GRAPHIC g75961mm23i002.jpg GRAPHIC 9366
20 GRAPHIC g75961mm23i003.jpg GRAPHIC 25519
21 GRAPHIC g75961mm23i004.jpg GRAPHIC 16073
22 GRAPHIC g75961moi001.jpg GRAPHIC 3813
23 GRAPHIC g75961mci001.jpg GRAPHIC 3813
24 GRAPHIC g75961mci002.jpg GRAPHIC 417
25 GRAPHIC g75961mci003.jpg GRAPHIC 386
26 GRAPHIC g75961mci004.jpg GRAPHIC 422
27 GRAPHIC g75961mm21i001.jpg GRAPHIC 22711
28 GRAPHIC g75961mm21i002.jpg GRAPHIC 20542
29 GRAPHIC g75961mm21i003.jpg GRAPHIC 19523
30 GRAPHIC g75961mm21i004.jpg GRAPHIC 33224
31 GRAPHIC g75961mm21i005.jpg GRAPHIC 33344
32 GRAPHIC g75961mm21i006.jpg GRAPHIC 18760
33 GRAPHIC g75961mm21i007.jpg GRAPHIC 7206
34 GRAPHIC g75961mm21i008.jpg GRAPHIC 38025
35 GRAPHIC g75961mgi001.jpg GRAPHIC 3813
36 GRAPHIC g75961mgi002.jpg GRAPHIC 417
37 GRAPHIC g75961mgi003.jpg GRAPHIC 386
38 GRAPHIC g75961mgi004.jpg GRAPHIC 422
39 GRAPHIC g75961mei001.jpg GRAPHIC 3813
40 GRAPHIC g75961mei002.jpg GRAPHIC 417
41 GRAPHIC g75961mei003.jpg GRAPHIC 386
42 GRAPHIC g75961mei004.jpg GRAPHIC 422
43 GRAPHIC g75961mi01i001.jpg GRAPHIC 1394
44 GRAPHIC g75961mm05i001.jpg GRAPHIC 30931
45 GRAPHIC g75961mm25i001.jpg GRAPHIC 20097
46 GRAPHIC g75961mm25i002.jpg GRAPHIC 22333
47 GRAPHIC g75961mm25i003.jpg GRAPHIC 38529
48 GRAPHIC g75961mm25i004.jpg GRAPHIC 22454
49 GRAPHIC g75961mm25i005.jpg GRAPHIC 24383
50 GRAPHIC g75961mm25i006.jpg GRAPHIC 44567
  Complete submission text file 0001104659-19-019416.txt   5404782
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 19726059
SIC: 2834 Pharmaceutical Preparations